Entrada Therapeutics, Inc.'s latest layoff filing, on April 29, 2025, states charges of approximately $2 million. As of November 14, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, April 29, 2025).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Entrada Therapeutics, Inc.
Free to see. No signup.
People from Entrada Therapeutics, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Entrada Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
Entrada Therapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Entrada Therapeutics have layoffs in 2025? What its filings say
Entrada Therapeutics, Inc. (CIK 1689375) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2025-04-29
Expected charges
In connection with the new strategic plan, the Company expects to incur aggregate charges of approximately $2 million in total expenses related to the reduction in force, consisting primarily of one-time severance payments and continued healthcare benefits for a specific period of time.
Timing
The costs are expected to be primarily incurred in the second quarter of 2025.
Also on the record for Entrada Therapeutics, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 10, 2026 | Stake report, Schedule 13D/A, by MPM BioVentures 2014, L.P. | 9.9% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by TCG Crossover GP I, LLC | 2.7% of the class | 5%+ stakes | Source |
| November 25, 2025 | Stake report, Schedule 13G, by TCG Crossover GP I, LLC | 5% of the class | 5%+ stakes | Source |
| November 18, 2025 | Stake report, Schedule 13D/A, by 5AM Ventures V, L.P. | 10.8% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by T. Rowe Price Associates, Inc. | 0.9% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by JANUS HENDERSON GROUP PLC | 4% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by T. Rowe Price Associates, Inc. | 6.8% of the class | 5%+ stakes | Source |
Keep reading
More on Entrada Therapeutics, Inc. and the records around it.
Entrada Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Sep 2026
- Who owns it
Companies that share a holder
- 5AM Ventures V, L.P. also filed stake reports on 1 other company: Rallybio Corp (May 2026)
- MPM BioVentures 2014, L.P. also filed stake reports on 1 other company: WEREWOLF THERAPEUTICS, INC. (May 2026)
- TCG Crossover GP I, LLC also filed stake reports on 6 other companies: Abivax SA (Aug 2026), Vistagen Therapeutics, Inc. (Aug 2026), Savara Inc. (Feb 2026)
Watch Entrada Therapeutics, Inc.
Get an email when Entrada Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Entrada Therapeutics, Inc.?
Want the whole picture on Entrada Therapeutics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Entrada Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Entrada Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for Entrada Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns Entrada Therapeutics, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/entrada-therapeutics